Antilipolytic effects of sulfonylurea drugs on induced lipolysis in isolated fat cells of the rat.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D003907:Dexamethasone / Q000494:pharmacology; D005227:Fatty Acids / Q000378:metabolism*; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005934:Glucagon / Q000494:pharmacology; D005990:Glycerol / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D007330:Insulin Antibodies; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D013806:Theophylline / Q000494:pharmacology; D014042:Tolazamide / Q000494:pharmacology; D014044:Tolbutamide / Q000494:pharmacology*
D000963:Antimetabolites; D005227:Fatty Acids; D005230:Fatty Acids, Nonesterified; D007004:Hypoglycemic Agents; D007330:Insulin Antibodies; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D005934:Glucagon; D014044:Tolbutamide; D014042:Tolazamide; D013806:Theophylline; D005990:Glycerol; D009638:Norepinephrine